Yabao has made great efforts to build a developed marketing network, set up four sales teams of generic drugs, agents, OTC and new drugs, reformed the marketing system, and continuously expanded its market share, with sales outlets all over the country. Troxerutin tablets, nimodipine tablets and compound reserpine tablets produced by the company have realized the integrated production from raw materials to tablets and injections, and the annual production and sales volume ranks first in the country. Ding Guier's belly button sticker (formerly Baby One Sticker) is a patented brand-name product exclusively produced in China, with an annual production and sales volume of 654.38+0 billion stickers and a sales income of 654.38+0.25 billion yuan in 2004.
Yabao has continuously increased the research and development of new products and attached importance to intellectual property protection. We have successively recovered 2/kloc-0 pieces of national new drug certificate and production approval, and 35 pieces of generic drug production approval. A large number of products, such as Ding Guier navel patch, Xiao Zhong Zhitong patch, safflower injection, Guanxinning injection, azithromycin injection and Zhenju Jiangya tablet, have shown strong competitive strength in the market. In recent years, Yabao applied for 45 patents in China National Intellectual Property Administration, and obtained 3 invention patent certificates and 16 design patent certificates, including Baobei Yiling, Yantongxiao and Ginkgo biloba sustained-release tablets. Declared the trademark 1 12 to the state, and obtained 24 certificates and 105 barcode. Yabao trademark was rated as a famous trademark in Shanxi Province.
After Yabao shares went public, the company decided to invest 500 million yuan and 300 million yuan respectively to build modern industrial parks in fenglingdu Provincial Economic Development Zone and Taiyuan National Economic Development Zone. At present, the first phase construction of fenglingdu Yabao Industrial Park with an investment of more than 200 million yuan and an area of 400 mu and Taiyuan Yabao Xinlong Industrial Park with an investment of more than/kloc-0.0 billion yuan and an area of 360 mu has been completed, both of which have passed GMP certification and formally put into production. After the operation of the two industrial parks, Yabao will leap into a brand-new development stage. After more than 30 years of drug production technology accumulation and the introduction of advanced pharmaceutical production technology, the company has mastered the technologies of dynamic extraction of traditional Chinese medicine, supercritical CO2 extraction, macroporous adsorption resin, membrane separation, ultrafine grinding, microwave low-temperature freeze-drying, fingerprint and so on.
In the field of preparations, we have mastered the technologies of transdermal absorption, enteric dissolution, solid dispersion, traditional Chinese medicine injection, sustained release and controlled release.
quality assurance
All dosage forms and all kinds of API production lines of the group company have passed the national GMP certification, and each company has established a strict quality assurance system. Drugs are always under strict control from the procurement of raw and auxiliary materials to the delivery of finished products. Each product has formulated internal control quality standards higher than the national standards, and has formulated operating specifications according to GMP. The quality inspection centers of all companies are equipped with internationally advanced testing and inspection equipment.
National enterprise technology center
The Enterprise Technology Center of Yabao Pharmaceutical Group was established in 1998, and was recognized as a provincial enterprise technology center by Shanxi Provincial People's Government in 1999.
On September 26th, 2008, it was approved by People's Republic of China (PRC) National Development and Reform Commission, Ministry of Science and Technology, Ministry of Finance, General Administration of Customs and State Taxation Administration of The People's Republic of China.
The Enterprise Technology Center of Yabao Pharmaceutical Group is a nationally recognized enterprise technology center and one of the fifteen enterprises enjoying preferential policies.